Abstract:Background: Cerium oxide nanoparticles (CeO2NPs) are potent scavengers of cellular reactive oxygen species (ROS). Their antioxidant properties make CeO2NPs promising therapeutic agents for bone diseases and bone tissue engineering. However, the effects of CeO2NPs on intracellular ROS production in osteoclasts (OCs) are still unclear. Numerous studies have reported that intracellular ROS are essential for osteoclastogenesis. The aim of this study was to explore the effects of CeO2NPs on osteoclast differentiation and the potential underlying mechanisms. Methods: The bidirectional modulation of osteoclast differentiation by CeO2NPs was explored by different methods, such as fluorescence microscopy, scanning electron microscopy (SEM), transmission electron microscopy (TEM), quantitative real-time polymerase chain reaction (qRT-PCR), and Western blotting. The cytotoxic and proapoptotic effects of CeO2NPs were detected by cell counting kit (CCK-8) assay, TdT-mediated dUTP nick-end labeling (TUNEL) assay, and flow cytometry. Results: The results of this study demonstrated that although CeO2NPs were capable of scavenging ROS in acellular environments, they facilitated the production of ROS in the acidic cellular environment during receptor activator of nuclear factor kappa-Β ligand (RANKL)-dependent osteoclast differentiation of bone marrow-derived macrophages (BMMs). CeO2NPs at lower concentrations (4.0 µg/mL to 8.0 µg/mL) promoted osteoclast formation, as shown by increased expression of Nfatc1 and C-Fos, F-actin ring formation and bone resorption. However, at higher concentrations (greater than 16.0 µg/mL), CeO2NPs inhibited osteoclast differentiation and promoted apoptosis of BMMs by reducing Bcl2 expression and increasing the expression of cleaved caspase-3, which may be due to the overproduction of ROS. Conclusion: This study demonstrates that CeO2NPs facilitate osteoclast formation at lower concentrations while inhibiting osteoclastogenesis in vitro by inducing the apoptosis of BMMs at higher concentrations by modulating cellular ROS levels.

Ceria Nanoparticles Alleviated Osteoarthritis Through Attenuating Senescence and Senescence-Associated Secretory Phenotype in Synoviocytes

Cerium oxide nanoparticles protect against chondrocytes and cartilage explants from oxidative stress via Nrf2/HO-1 pathway in temporomandibular joint osteoarthritis

Nanoparticle-activated SIRT3/SOD2 Axis Involves Amelioration of Chondrocyte Senescence to Delay Osteoarthritis Progression

Cerium Oxide Nanozyme Attenuates Periodontal Bone Destruction by Inhibiting the ROS–NFκB Pathway

Controlled Release of Ceria and Ferric Oxide Nanoparticles via Collagen Hydrogel for Enhanced Osteoarthritis Therapy

Cationic Mesoporous Silica Nanoparticles Alleviate Osteoarthritis by Targeting Multiple Inflammatory Mediators.

Oxygen vacancy-engineered cerium oxide mediated by copper-platinum exhibit enhanced SOD/CAT-mimicking activities to regulate the microenvironment for osteoarthritis therapy

Reactive Oxygen Species-Scavenging Nanoparticles Coated with Chondroitin Sulfate Protect Cartilage Against Osteoarthritis in Vivo

Nanoceria provides antioxidant and osteogenic properties to mesoporous silica nanoparticles for osteoporosis treatment

Curcumin-loaded biomimetic nanosponges for osteoarthritis alleviation by synergistically suppressing inflammation and ferroptosis

Au@CeO2 Yolk-Shell Nanozymes Restore Mitochondrial Dynamics and Enhance Chondrogenic Drug Response for Cartilage Regeneration in Osteoarthritis

A Reactive Oxygen Species "Sweeper" Based on Hollow Mesopore Cerium Oxide Nanospheres for Targeted and Anti-Inflammatory Management of Osteoarthritis

Urchin-like Ceria Nanoparticles for Enhanced Gene Therapy of Osteoarthritis.

Nitidine Chloride Alleviates Inflammation and Cellular Senescence in Murine Osteoarthritis Through Scavenging ROS

Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis Via Regulating the MAPK/NF-κB-Autophagy Pathway

Cartilage-targeting and Inflammatory-Responsive Nanocarriers for Effective Osteoarthritis Treatment Via Reactive Oxygen Species Scavenging and Anti-Angiogenesis

Prodrug-inspired therapeutics: albuminized ceria nanozymes for osteoarthritis treatment

NIR-driven Polydopamine-Based Nanoenzymes As ROS Scavengers to Suppress Osteoarthritis Progression

Nanoparticle-delivered quercetin exhibits enhanced efficacy in eliminating iron-overloaded senescent chondrocytes

Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment

Cerium Oxide Nanoparticles Regulate Osteoclast Differentiation Bidirectionally by Modulating the Cellular Production of Reactive Oxygen Species